Telesair

Telesair is a private, commercial-stage medical device company founded in 2018, specializing in innovative respiratory care solutions. The company's core technology is the Bonhawa HFOT system, a standalone humidified high-flow oxygen therapy device designed by experts with deep ventilation experience. Led by a seasoned executive team with decades in medtech, Telesair is targeting the growing market for portable, effective respiratory support across care settings. The company appears to be in an early revenue phase, leveraging its patented technology and clinical expertise to establish a market position.

Standalone High Flow Oxygen Therapy (HFOT) system featuring precise heated and humidified gas delivery with adjustable flow (pediatric & adult), temperature, and oxygen concentration, designed with ventilation expertise and integrated with software/AI for smarter respiratory care.

Telesair competes in the crowded high-flow oxygen therapy market against dominant players like Fisher & Paykel Healthcare, Vyaire Medical, Philips, and ResMed. Its differentiation strategy centers on its standalone device design, ventilation expertise heritage, and focus on enabling care across multiple settings.